Cargando…

A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer

Background: PIK3CA pathways are the most frequently mutated oncogenic pathway in head and neck squamous cell carcinoma (HNSCC), including virally driven HNCs. PIK3CA is involved in the PI3K-PTEN-mTOR signalling pathway. PIK3CA has been implicated in HNSCC progression and PIK3CA mutations may serve a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Henri, Kulasinghe, Arutha, Allcock, Richard J.N., Tan, Lit Yeen, Mokany, Elisa, Kenny, Liz, Punyadeera, Chamindie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315660/ https://www.ncbi.nlm.nih.gov/pubmed/30501041 http://dx.doi.org/10.3390/diagnostics8040079

Ejemplares similares

A Collective Route to Head and Neck Cancer Metastasis
por: Kulasinghe, Arutha, et al.
Publicado: (2018)

PD-L1 expressing circulating tumour cells in head and neck cancers
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients
por: Kulasinghe, Arutha, et al.
Publicado: (2021)

Impact of label-free technologies in head and neck cancer circulating tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
por: Kulasinghe, Arutha, et al.
Publicado: (2019)

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
por: Kulasinghe, Arutha, et al.
Publicado: (2018)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
por: Kulasinghe, Arutha, et al.
Publicado: (2018)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Short term ex-vivo expansion of circulating head and neck tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas
por: Tang, Kai Dun, et al.
Publicado: (2017)

Circulating biomarkers in patients with glioblastoma
por: Müller Bark, Juliana, et al.
Publicado: (2019)

Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
por: Zhou, Jian, et al.
Publicado: (2019)

The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells
por: Kulasinghe, Arutha, et al.
Publicado: (2020)

DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers
por: Ekanayake Weeramange, Chameera, et al.
Publicado: (2020)

Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
por: Kulasinghe, Arutha, et al.
Publicado: (2019)

Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients
por: Wan, Yunxia, et al.
Publicado: (2017)

Head and neck cancer N-glycome traits are cell line and HPV status–dependent
por: Rasheduzzaman, Mohammad, et al.
Publicado: (2022)

Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
por: Müller Bark, Juliana, et al.
Publicado: (2021)

Current trends in the etiology and diagnosis of HPV-related head and neck cancers
por: Chai, Ryan C, et al.
Publicado: (2015)

Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer
por: Kapeleris, Joanna, et al.
Publicado: (2020)

Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges
por: Basnayake, B. W. M. Thilini J., et al.
Publicado: (2023)

Application of circulating tumour cells to predict response to treatment in head and neck cancer
por: Zhang, Xi, et al.
Publicado: (2022)

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
por: Huang, Xiaomin, et al.
Publicado: (2023)

Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR
por: Tan, Lit Yeen, et al.
Publicado: (2017)

The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers
por: Lim, Yenkai, et al.
Publicado: (2018)

Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
por: Lim, Yenkai, et al.
Publicado: (2016)

Unlocking the Potential of Saliva-Based Test to Detect HPV-16-Driven Oropharyngeal Cancer
por: Tang, Kai Dun, et al.
Publicado: (2019)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

4373 Defining the role of non-canonical PIK3CA mutations in head and neck squamous cell carcinoma
por: Lee, Michelle Ji-Eun, et al.
Publicado: (2020)

Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand
por: Dechaphunkul, Arunee, et al.
Publicado: (2022)

A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients
por: Chai, Ryan C., et al.
Publicado: (2016)

mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations
por: Wang, Zhiyong, et al.
Publicado: (2014)

Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
por: Li, Hua, et al.
Publicado: (2022)

DNA Methylation at the Novel CpG Sites in the Promoter of MED15/PCQAP Gene as a Biomarker for Head and Neck Cancers
por: Ovchinnikov, Dmitry A, et al.
Publicado: (2014)

Analysis of human leukocyte antigen associations in human papillomavirus–positive and –negative head and neck cancer: Comparison with cervical cancer
por: Ekanayake Weeramange, Chameera, et al.
Publicado: (2022)

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
por: Hedberg, Matthew L., et al.
Publicado: (2019)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n462b6kclkam6rocujj8on57u1